Literature DB >> 25703803

Knockdown of CkrL by shRNA deteriorates hypoxia/reoxygenation-induced H9C2 cardiomyocyte apoptosis and survival inhibition Via Bax and downregulation of P-Erk1/2.

Zhi-Sheng Zhang1, Dong-Yan Yang, Yan-Bo Fu, Lei Zhang, Qian-Ping Zhao, Gang Li.   

Abstract

Integrin β1 subunit and its downstream molecule integrin-linked kinase and focal adhesion kinase have been confirmed to be essential to cell survival and inhibition of apoptosis and hypoxia/reoxygenation (H/R)-induced injuries in cardiomyocytes. However, it is still unclear whether CrkL [v-crk avian sarcoma virus CT-10 oncogene homolog (Crk)-like], which acts also as a component of the integrin pathway, could also affect H/R-induced injuries in the cardiomyocytes. The rat-derived H9C2 cardiomyocytes were infected with a CrkL small hairpin RNA interference recombinant lentivirus, which knockdowns the endogenous CrkL expression in the cardiomyocytes. Apoptosis, cell proliferation and survival were examined in the H9C2 cardiomyocytes treated with either H/R or not. Results showed that knockdown of CrkL could significantly increase apoptosis and inhibition of the cell proliferation and survival and deteriorate the previously mentioned injuries induced by H/R. In contrast, overexpression of human CrkL could relieve the exacerbation of the previously mentioned injuries induced by CrkL knockdown in the H9C2 cardiomyocytes via regulation of Bax and extracellular signal-regulated kinase1/2 (p-ERK1/2). In conclusion, these results confirmed that knockdown of CrkL could deteriorate H/R-induced apoptosis and cell survival inhibition in rat-derived H9C2 cardiomyocytes via Bax and downregulation of p-ERK1/2. It implies that CrkL could mitigate H/R-induced injuries in the cardiomyocytes.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Bax; CrkL (v-crk avian sarcoma virus CT-10 oncogene homolog-like); H9C2 cardiomyocyte line; apoptosis; cell proliferation; cell survival; hypoxia/reoxygenation; phosphorylated extracellular signal-regulated kinase1/2 (p-ERK1/2)

Mesh:

Substances:

Year:  2015        PMID: 25703803     DOI: 10.1002/cbf.3093

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  4 in total

1.  Inactivation of indicator microorganisms and biological hazards by standard and/or alternative processing methods in Category 2 and 3 animal by-products and derived products to be used as organic fertilisers and/or soil improvers.

Authors:  Konstantinos Koutsoumanis; Ana Allende; Declan Bolton; Sara Bover-Cid; Marianne Chemaly; Robert Davies; Alessandra De Cesare; Lieve Herman; Friederike Hilbert; Roland Lindqvist; Maarten Nauta; Luisa Peixe; Giuseppe Ru; Marion Simmons; Panagiotis Skandamis; Elisabetta Suffredini; Benedetta Bottari; Enda Cummins; Kari Ylivainio; Irene Muñoz Guajardo; Angel Ortiz-Pelaez; Avelino Alvarez-Ordóñez
Journal:  EFSA J       Date:  2021-12-02

2.  Circ_0001206 regulates miR-665/CRKL axis to alleviate hypoxia/reoxygenation-induced cardiomyocyte injury in myocardial infarction.

Authors:  Dongmei Wang; Limei Tian; Yan Wang; Xiaoli Gao; Hanbo Tang; Junbo Ge
Journal:  ESC Heart Fail       Date:  2022-01-13

Review 3.  The circRNA-miRNA/RBP regulatory network in myocardial infarction.

Authors:  Lei Zhang; Yuan Zhang; Fei Yu; Xin Li; Huijuan Gao; Peifeng Li
Journal:  Front Pharmacol       Date:  2022-07-18       Impact factor: 5.988

4.  CXCR7/p-ERK-Signaling Is a Novel Target for Therapeutic Vasculogenesis in Patients with Coronary Artery Disease.

Authors:  Zheng Cao; Xinzhu Tong; Wenhao Xia; Long Chen; Xiaoyu Zhang; Bingbo Yu; Zhen Yang; Jun Tao
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.